Patents by Inventor James Albert Napper

James Albert Napper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride
    Publication number: 20030157169
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: August 28, 2002
    Publication date: August 21, 2003
    Applicant: SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20030129246
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: February 26, 2003
    Publication date: July 10, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Controlled release dosage form of [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
    Patent number: 6468560
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: October 22, 2002
    Assignees: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20020150618
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: June 10, 2002
    Publication date: October 17, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
    Publication number: 20020031550
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: September 19, 2001
    Publication date: March 14, 2002
    Applicant: SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20010018074
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: January 12, 2001
    Publication date: August 30, 2001
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
    Publication number: 20010003588
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: January 12, 2001
    Publication date: June 14, 2001
    Applicant: SmithKline Beecham Corporation
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau